INDIANAPOLIS, Ind., April 16, 2008 — Adding to its impressive cadre of Board of Directors members, BioCrossroads announces that Sidney Taurel, Chairman of the Board of Eli Lilly and Company, has been elected to the organization’s board. Taurel recently retired from his role as Lilly’s Chief Executive Officer, having spent a 37-year tenure in a variety of roles at the company, including President of the pharmaceutical division and President and Chief Operating Officer.
Taurel will continue as chairman of Lilly until the end of the year. In addition, he is past chairman of the Board of Directors of Pharmaceutical Research and Manufacturers of America (PhRMA). He is also a member of the boards of both IBM Corporation and McGraw-Hill Companies, Inc. and serves on the board of overseers of the Columbia Business School and the Executive Committee of the Business Council. Locally, he serves as a trustee at the Indianapolis Museum of Art, and he is on the board of the Indianapolis Tennis Championships. Since April 2007, he has served on the U.S. Advisory Committee for Trade Policy and Negotiations. He is also an officer in the French Legion of Honor.
“A globally-known thought leader and innovator, Sidney’s business acumen and knowledge of the pharmaceutical and biotech industries are incredibly relevant in our work to help shape the future of Indiana’s economic growth, as well as for improving health care for patients at home and around the world,” said Dr. August Watanabe, Chairman of the Board of BioCrossroads. “As BioCrossroads continues to focus on searching for the best life sciences market opportunities and building innovative business and university collaborations, Sidney’s input and perspective will be invaluable.”
“BioCrossroads has been able to underscore the importance of Indiana’s life sciences community. The momentum is building, and we’re receiving national attention for our efforts,” said Taurel. “With our academic, corporate, research and philanthropic strengths, we possess an unmatched wealth of resources. I look forward to working with BioCrossroads as we identify and capture opportunities that will fuel the growth of this important industry.”
BioCrossroads (www.biocrossroads.com) is Indiana’s initiative to grow the life sciences, a public-private collaboration that supports the region’s research and corporate strengths while encouraging new business development. BioCrossroads provides money and support to life sciences businesses, launches new life sciences businesses, expands collaboration and partnerships among Indiana’s life science institutions, expands science education and markets Indiana’s life sciences industry.